News

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

0

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant.

Genetic vulnerability to ADHD signals risk of Alzheimer’s disease in old age

Previous article

T-DXd shows high efficacy in HER2-positive breast cancer patients previously treated with T-DM1

Next article

You may also like

Comments

Leave a reply

Your email address will not be published. Required fields are marked *

More in News